MedPath

Propofol

Generic Name
Propofol
Brand Names
Diprivan
Drug Type
Small Molecule
Chemical Formula
C12H18O
CAS Number
2078-54-8
Unique Ingredient Identifier
YI7VU623SF
Background

Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.

Indication

Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.

Associated Therapies
Induction of anesthesia therapy, Maintenance of anesthesia therapy, Monitored anesthesia care sedation, Sedative therapy

Efficacy of Propofol-Ketamine and Sevoflurane in Children Undergoing Magnetic Resonance Imaging

Not Applicable
Not yet recruiting
Conditions
Recovery Period
Hypoxemia
Patient Safety
Interventions
First Posted Date
2025-02-18
Last Posted Date
2025-04-27
Lead Sponsor
Kocaeli City Hospital
Target Recruit Count
180
Registration Number
NCT06832683

Effect of Propofol Versus Remimazolam Intravenous Anesthesia on Respiratory Depression

Phase 4
Not yet recruiting
Conditions
Respiratory Depression
Interventions
First Posted Date
2025-02-10
Last Posted Date
2025-02-10
Lead Sponsor
Second Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
96
Registration Number
NCT06816173
Locations
🇨🇳

The second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China

Combination of Remimazolam and Propofol During Drug-induced Sleep Endoscopy

Phase 4
Conditions
Sedative Effect During Drug-induced Sleep Endoscopy
Obstructive Sleep Apnea (OSA)
Interventions
Drug: Remimazolam and Propofol
Drug: Midazolam and propofol
First Posted Date
2025-01-20
Last Posted Date
2025-01-20
Lead Sponsor
Dan Liu
Target Recruit Count
80
Registration Number
NCT06784479
Locations
🇨🇳

Respiratory Endoscopy Center of Tianjin Medical University General Hospital, Tianjin, Tianjin, China

Comparison of Remimazolam and Propofol in Endoscopic Examinations and Treatments

Phase 4
Recruiting
Conditions
Postoperative Complications
Respiratory Depression
Postoperative Nausea
Vomiting
Constipation
Interventions
First Posted Date
2025-01-16
Last Posted Date
2025-05-08
Lead Sponsor
Kaohsiung Veterans General Hospital.
Target Recruit Count
90
Registration Number
NCT06777758
Locations
🇨🇳

Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan

The Effect of General Anesthesia with Remimazolam and Propofol on Rhythmic State and Cognitive Function

Not Applicable
Not yet recruiting
Conditions
Cognitive Functioning
Propofol
Remimazolam
Circadian Rhythm
Interventions
First Posted Date
2025-01-15
Last Posted Date
2025-02-14
Lead Sponsor
The Second Affiliated Hospital of Chongqing Medical University
Target Recruit Count
174
Registration Number
NCT06775366
Locations
🇨🇳

The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China

Lidocaine-based Versus Opioid-based Induction of Anesthesia in Emergency Laparotomy

Phase 4
Recruiting
Conditions
Post-induction Hypotension
Lidocaine
Opioid
Emergency Laparotomy
Interventions
First Posted Date
2025-01-13
Last Posted Date
2025-01-22
Lead Sponsor
Cairo University
Target Recruit Count
150
Registration Number
NCT06772727
Locations
🇪🇬

Faculty of Medicine, Cairo University, Cairo, Egypt

Comparison of Safety and Efficacy for Different Sedation Regimens During Colonoscopy

Phase 4
Not yet recruiting
Conditions
Deep Sedations
Conscious Sedation
Colonoscopy
Interventions
First Posted Date
2025-01-08
Last Posted Date
2025-01-08
Lead Sponsor
Qassim Health Cluster
Target Recruit Count
157
Registration Number
NCT06763705
Locations
🇸🇦

King Saud Hospital, Unaizah, Qassim, Saudi Arabia

DISE in Pediatric Sleep Disordered Breathing

Phase 2
Withdrawn
Conditions
Sleep Disordered Breathing
Drug Induced Sleep Disorder
Interventions
First Posted Date
2025-01-03
Last Posted Date
2025-01-03
Lead Sponsor
University of Iowa
Registration Number
NCT06756971

Effect of Remimazolam Versus Dexmedetomidine on the Incidence of Delirium After Elective Cardiac Surgery with Cardiopulmonary Bypass: a Prospective Randomized Controlled Trial

Early Phase 1
Not yet recruiting
Conditions
Delirium - Postoperative
Interventions
First Posted Date
2025-01-01
Last Posted Date
2025-01-01
Lead Sponsor
Assiut University
Target Recruit Count
111
Registration Number
NCT06756178
Locations
🇪🇬

Assiut University, Assiut, Egypt

Ketamine Sedation As Neuroprotective Agent Following Out-of-hospital Cardiac Arrest

Phase 2
Recruiting
Conditions
Out-of-hospital Cardiac Arrest (OHCA)
Interventions
First Posted Date
2024-12-20
Last Posted Date
2024-12-20
Lead Sponsor
Christian Hassager
Target Recruit Count
282
Registration Number
NCT06744361
Locations
🇩🇰

Department of Cardiology, Rigshospitalet, Copenhagen, Denmark

🇩🇰

Odense University Hospital, Odense C, Denmark

© Copyright 2025. All Rights Reserved by MedPath